Related references
Note: Only part of the references are listed.The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom
Katharina Schwarze et al.
GENETICS IN MEDICINE (2020)
Effect of time interval from diagnosis to treatment for non-small cell lung cancer on survival: a national cohort study in Taiwan
Chang-Hung Tsai et al.
BMJ OPEN (2020)
Molecular characterization of cancers with NTRK gene fusions
Zoran Gatalica et al.
MODERN PATHOLOGY (2019)
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 29, pg iv192, 2018)
D. Planchard et al.
ANNALS OF ONCOLOGY (2019)
Variation in the time to treatment for stage III and IV non-small cell lung cancer patients for hospitals in the Netherlands
M. van de Ven et al.
LUNG CANCER (2019)
Molecular testing strategies in non-small cell lung cancer: optimizing the diagnostic journey
Jeffrey P. Gregg et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2019)
Real-world prevalence of programmed death ligand 1 expression in locally advanced or metastatic non small-cell lung cancer: The global, multicenter EXPRESS study
M. Dietel et al.
LUNG CANCER (2019)
bupaR: Enabling reproducible business process analysis
Gert Janssenswillen et al.
KNOWLEDGE-BASED SYSTEMS (2019)
Current and future perspectives of liquid biopsies in genomics-driven oncology
Ellen Heitzer et al.
NATURE REVIEWS GENETICS (2019)
Non-Small Cell Lung Cancer, Version 1.2020 Featured Updates to the NCCN Guidelines
David S. Ettinger et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Old Soldiers Never Die: Is There Still a Role for Immunohistochemistry in the Era of Next-Generation Sequencing Panel Testing?
Ming Sound Tsao et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
Neal I. Lindeman et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2018)
Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study
Patricia Marino et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2018)
Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature
Katharina Schwarze et al.
GENETICS IN MEDICINE (2018)
Real-world utilization of molecular diagnostic testing and matched drug therapies in the treatment of metastatic cancers
Anita Chawla et al.
JOURNAL OF MEDICAL ECONOMICS (2018)
Lung cancer: current therapies and new targeted treatments
Fred R. Hirsch et al.
LANCET (2017)
Precision Diagnosis and Treatment for Advanced Non-Small-Cell Lung Cancer
Martin Reck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Changing the Therapeutic Landscape in Non-small Cell Lung Cancers: the Evolution of Comprehensive Molecular Profiling Improves Access to Therapy
Joshua K. Sabari et al.
CURRENT ONCOLOGY REPORTS (2017)
Lung adenocarcinoma: from molecular basis to genome-guided therapy and immunotherapy
Roberto Chalela et al.
JOURNAL OF THORACIC DISEASE (2017)
The cost and cost trajectory of whole-genome analysis guiding treatment of patients with advanced cancers
Deirdre Weymann et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2017)
Resource utilization in lung cancer diagnostic procedures: Current use and budget consequences
Sander Brinkhof et al.
PLOS ONE (2017)
Genomic Profiling of Advanced Non-Small Cell Lung Cancer in Community Settings: Gaps and Opportunities
Martin E. Gutierrez et al.
CLINICAL LUNG CANCER (2017)
Beyond ALK and ROS1: RET, NTRK, EGFR and BRAF gene rearrangements in non-small cell lung cancer
Anna F. Farago et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2017)
Cost analysis of whole genome sequencing in German clinical practice
Marika Ploethner et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2017)
Genomic Sequencing Procedure Microcosting Analysis and Health Economic Cost-Impact Analysis A Report of the Association for Molecular Pathology
Linda M. Sabatini et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2016)
The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis
Yue-Lun Zhang et al.
Oncotarget (2016)
Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancer
C. Lim et al.
ANNALS OF ONCOLOGY (2015)
Discovery of clinical pathway patterns from event logs using probabilistic topic models
Zhengxing Huang et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2014)
Evidence of increasing mortality with longer diagnostic intervals for five common cancers: A cohort study in primary care
Marie Louise Torring et al.
EUROPEAN JOURNAL OF CANCER (2013)
Summarizing clinical pathways from event logs
Zhengxing Huang et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2013)
Share Paper
